• Product NameBML-190
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityBML-190 is a selective cannabinoid CB2 receptor inverse agonist with Ki of 435 nM, with 50-fold selectivity over CB1 receptor.
• Target NameCannabinoid Receptor agonist
• CAS No. 2854-32-2
• Calculated MW 426.89
• Formulation C23H23ClN2O4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)N1CCOCC1 |c:4,6,17,21,t:2,12,14|
  Pathways:GPCR/G Protein
  Receptor:CB2
  Boling pt:
  Melting pt:
  Solubility:DMSO:22 mg/mL (51.53 mM)Ethanol:<1 mg/mL (<1 mM)Water:<1 mg/mL (<1 mM)
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. New DC, et al. FEBS Lett. 2003, 536(1-3), 157-160.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting